Efficacy In Severe PatientsDemonstrating some degree of efficacy in the sickest of the sick patients could be a respectable result that allows epetraborole to distinguish itself.
Pipeline PotentialAN2 has a pipeline of overlooked programs that leverages its boron-based technology; the company could generate value by creating a market they could dominate.
Quality Of Life ImprovementEpetraborole showed a statistically significant and clinically meaningful improvement in a quality of life measure compared to placebo, even in patients with advanced and severe disease.